Rua Bioscience Limited (RUA.NZ)
NZD 0.03
(0.0%)
NZD 0.03
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | - NZD | 0.0% |
| 2023 | 67.85 Thousand NZD | -90.24% |
| 2022 | 695.45 Thousand NZD | -23.13% |
| 2021 | 904.72 Thousand NZD | 8306.65% |
| 2020 | 10.76 Thousand NZD | -78.41% |
| 2019 | 49.85 Thousand NZD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 FY | - NZD | -100.0% |
| 2024 Q1 | 124.02 Thousand NZD | 0.0% |
| 2024 Q4 | - NZD | 0.0% |
| 2024 Q2 | 124.02 Thousand NZD | 0.0% |
| 2023 Q3 | 67.85 Thousand NZD | -44.85% |
| 2023 Q1 | 123.03 Thousand NZD | -82.31% |
| 2023 Q4 | 67.85 Thousand NZD | 0.0% |
| 2023 FY | 67.85 Thousand NZD | -90.24% |
| 2023 Q2 | 123.03 Thousand NZD | 0.0% |
| 2022 Q1 | 750.9 Thousand NZD | -17.0% |
| 2022 FY | 695.45 Thousand NZD | -23.13% |
| 2022 Q4 | 695.45 Thousand NZD | 0.0% |
| 2022 Q3 | 695.45 Thousand NZD | -7.38% |
| 2022 Q2 | 750.9 Thousand NZD | 0.0% |
| 2021 Q1 | 188.25 Thousand NZD | 1649.24% |
| 2021 Q3 | 810.12 Thousand NZD | 330.34% |
| 2021 Q4 | 904.72 Thousand NZD | 11.68% |
| 2021 Q2 | 188.25 Thousand NZD | 0.0% |
| 2021 FY | 904.72 Thousand NZD | 8306.65% |
| 2020 FY | 10.76 Thousand NZD | -78.41% |
| 2020 Q4 | 10.76 Thousand NZD | 0.0% |
| 2020 Q3 | 10.76 Thousand NZD | 0.0% |
| 2020 Q1 | - NZD | 0.0% |
| 2019 FY | 49.85 Thousand NZD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AFT Pharmaceuticals Limited | 28.2 Million NZD | 100.0% |
| Greenfern Industries Limited | - NZD | NaN% |